DBF4B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.763600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.471600E-01
Normal-vs-Stage2
2.433600E-01
Normal-vs-Stage3
2.607200E-01
Normal-vs-Stage4
4.094600E-01
Stage1-vs-Stage2
4.080600E-01
Stage1-vs-Stage3
2.730600E-01
Stage1-vs-Stage4
2.986800E-01
Stage2-vs-Stage3
3.858800E-01
Stage2-vs-Stage4
5.357200E-01
Stage3-vs-Stage4
7.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.415000E-01
Normal-vs-AfricanAmerican
1.716050E-01
Normal-vs-Asian
4.467800E-01
Caucasian-vs-AfricanAmerican
2.670000E-01
Caucasian-vs-Asian
8.946400E-02
AfricanAmerican-vs-Asian
5.147000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.196400E-01
Normal-vs-Female
5.572200E-01
Male-vs-Female
6.385800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.666600E-01
Normal-vs-Age(41-60Yrs)
6.108600E-01
Normal-vs-Age(61-80Yrs)
3.808400E-01
Normal-vs-Age(81-100Yrs)
4.575800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.849600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.360000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.995400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.205400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.594300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.285200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.689590E-01
Normal-vs-Daily Drinker
7.746200E-01
Normal-vs-Weekly Drinker
4.639400E-01
Normal-vs-Occasional Drinker
4.650400E-01
Normal-vs-Social Drinker
9.986400E-01
Non Drinker-vs-Daily Drinker
3.855200E-01
Non Drinker-vs-Weekly Drinker
3.603400E-01
Non Drinker-vs-Occasional Drinker
2.359600E-01
Non Drinker-vs-Social Drinker
6.980100E-02
Daily Drinker-vs-Weekly Drinker
7.721800E-01
Daily Drinker-vs-Occasional Drinker
8.354000E-01
Daily Drinker-vs-Social Drinker
5.590000E-01
Weekly Drinker-vs-Occasional Drinker
8.893000E-01
Weekly Drinker-vs-Social Drinker
2.724400E-01
Occasional Drinker-vs-Social Drinker
2.649000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.992600E-01
Normal-vs-Grade 2
8.728000E-01
Normal-vs-Grade 3
8.833000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.382020E-01
Grade 1-vs-Grade 3
1.603570E-01
Grade 1-vs-Grade 4
8.992600E-01
Grade 2-vs-Grade 3
7.763200E-01
Grade 2-vs-Grade 4
8.728000E-01
Grade 3-vs-Grade 4
8.833000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.370400E-01
Normal-vs-NonDiabetic
7.000800E-01
Diabetic-vs-NonDiabetic
3.421800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.512400E-01
Normal-vs-NoPancreatitis
4.813600E-01
Pancreatitis-vs-NoPancreatitis
7.831400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.614200E-01
Normal-vs-N1
2.654200E-01
N0-vs-N1
4.006800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.747600E-01
Normal-vs-TP53-NonMutant
9.131200E-01
TP53-Mutant-vs-TP53-NonMutant
1.867400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
